Cardiff Oncology, Inc. (CRDF)

[pottsvision]

Significant reason for my investment here is the fact that this company is funded into phase 3... TROV has quite a history of dilution - its pretty nasty and has left MANY bitter shareholders... but that is par for the biotech course - no/little revenues for years while having to fund expensive research. Some do better than others in this period, TROV has done what it needed to do to get to this point - and that was piss alot of people off.

I'll be pissed off too if they do another offering...

But also par for the biotech course is to get in right when that light starts flickering at the end of the tunnel and HOLD through the crazy volatility.

The data satisfies me... I see the market for the drug(s) they are producing, I see that market extending into the future... making this tech worth, without a hint of exaggeration, 100x what it is valued at today - if not more. I'm no expert, but having an expert put a $23 target on this is somewhat assuring - that target could easily get another digit in phase 3.

Given the incredible risk I am certainly putting a few too many eggs in this basket - but my oh my if this does find itself a billion+ mkt cap I and anyone else holding from these levels (or lower - though I suspect *plenty* of profit taking cut out all but the strongest hands) will be quite happy.